Anil Gupta, MD; Yaneicy Gonzalez-Rojas, MD; Erick Juarez, MD; et al.
doi : 10.1001/jama.2022.2832
JAMA. 2022;327(13):1236-1246
Importance Older patients and those with comorbidities who are infected with SARS-CoV-2 may be at increased risk of hospitalization and death. Sotrovimab is a neutralizing antibody for the treatment of high-risk patients to prevent COVID-19 progression.
REMAP-CAP Writing Committee for the REMAP-CAP Investigators
doi : 10.1001/jama.2022.2910
JAMA. 2022;327(13):1247-1259
Importance The efficacy of antiplatelet therapy in critically ill patients with COVID-19 is uncertain.
Katia Bruxvoort, PhD; Jeff Slezak, MS; Lei Qian, PhD; et al.
doi : 0.1001/jama.2022.2540
JAMA. 2022;327(13):1260-1268
Importance The 2-dose hepatitis B vaccine with a cytosine phosphoguanine adjuvant (HepB-CpG vaccine; Heplisav-B) generated higher seroprotection in prelicensure trials than did a 3-dose hepatitis B vaccine with an aluminum hydroxide adjuvant (HepB-alum vaccine; Engerix-B). However, in 1 trial, a higher number of acute myocardial infarction (MI) events were observed among those who received the HepB-CpG vaccine than among those who received the HepB-alum vaccine, an outcome requiring further study.
Ana Cecilia Ulloa, MPH; Sarah A. Buchan, PhD; Nick Daneman, MD, MSc; et al.
doi : 10.1001/jama.2022.2274
JAMA. 2022;327(13):1286-1288
Heather S. Hipp, MD; Sara Crawford, PhD; Sheree Boulet, DrPH, MPH; et al.
doi : 10.1001/jama.2022.1892
JAMA. 2022;327(13):1288-1290
Lawrence Corey, MD; Russell Corbett-Detig, PhD; Chris Beyrer, MD, MPH
doi : 10.1001/jama.2022.3517
JAMA. 2022;327(13):1227-1228
Eli Y. Adashi, MD, MS; I. Glenn Cohen, JD
doi : 10.1001/jama.2022.3382
JAMA. 2022;327(13):1229-1230
Michael S. Sinha, MD, JD, MPH; Aaron S. Kesselheim, MD, JD, MPH; Christopher T. Robertson, PhD, JD
doi : 10.1001/jama.2022.2043
JAMA. 2022;327(13):1231-1232
Jean M. Connors, MD; Paul M Ridker, MD, MPH
doi : 10.1001/jama.2022.2361
JAMA. 2022;327(13):1234-1235
Andres M. Kanner, MD; Manuel Melo Bicchi, MD
doi : 10.1001/jama.2022.3880
JAMA. 2022;327(13):1269-1281
Mathias J. Holmberg, MD, MPH, PhD; Lars W. Andersen, MD, MPH, PhD, DMSc
doi : 10.1001/jama.2022.1820
JAMA. 2022;327(13):1282-1283
Esther de Boer, MD, PhD; Irina Petrache, MD; Michael P. Mohning, MD
doi : 10.1001/jama.2022.2037
JAMA. 2022;327(13):1284-1285
Melissa Suran, PhD, MSJ
doi : 10.1001/jama.2022.4289
JAMA. 2022;327(13):1214-1215
Rita Rubin, MA
doi : 10.1001/jama.2022.3834
JAMA. 2022;327(13):1216-1217
Anita Slomski
doi : 10.1001/jama.2022.4370
JAMA. 2022;327(13):1218
Anita Slomski
doi : 10.1001/jama.2022.3350
JAMA. 2022;327(13):1218
Anita Slomski
doi : 10.1001/jama.2022.4371
JAMA. 2022;327(13):1218
Anita Slomski
doi : 10.1001/jama.2022.4372
JAMA. 2022;327(13):1218
Howard D. Larkin
doi : 10.1001/jama.2022.4556
JAMA. 2022;327(13):1219
Howard D. Larkin
doi : 10.1001/jama.2022.3970
JAMA. 2022;327(13):1219
Howard D. Larkin
doi : 10.1001/jama.2022.4561
JAMA. 2022;327(13):1219
Linda Yue, MD; Jessica Berman, MD
doi : 10.1001/jama.2022.1980
JAMA. 2022;327(13):1300
Hong-Qiu Gu, PhD
doi : 10.1001/jama.2022.1425
JAMA. 2022;327(13):1290
Wayne A. Ray, PhD; Katherine T. Murray, MD
doi : 10.1001/jama.2022.1428
JAMA. 2022;327(13):1290
Chih-Sung Liang, MD; Ping-Tao Tseng, MD; Kuan-Pin Su, PhD
doi : 10.1001/jama.2022.2030
JAMA. 2022;327(13):1290-1291
Mu-Hong Chen, MD; Chih-Sung Liang, MD; Kuan-Pin Su, PhD
doi : 10.1001/jama.2022.2027
JAMA. 2022;327(13):1291-1292
Olivia I. Okereke, MD, SM; David Mischoulon, MD, PhD; JoAnn E. Manson, MD, DrPH
doi : 10.1001/jama.2022.2033
JAMA. 2022;327(13):1292
Shu-Tsen Liu, MD; Chieh-Chung Lin, MD; James Cheng-Chung Wei, MD, PhD
doi : 10.1001/jama.2022.2164
JAMA. 2022;327(13):1292-1293
Francesca Crovetto, MD, PhD; Fà tima Crispi, MD, PhD; Eduard Gratacós, MD, PhD
doi : 10.1001/jama.2022.2167
JAMA. 2022;327(13):1293-1294
S. Shah, MD
doi : 10.1001/jama.2022.3950
JAMA. 2022;327(13):1294
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟